FDA Panel Gives Thumbs Up To DuraSeal Xact Spine Surgery Sealant
This article was originally published in The Gray Sheet
Executive Summary
Covidien's DuraSeal Xact dural repair sealant for spine surgery should be approved with conditions, FDA's Neurological Devices panel recommended in a unanimous 4-0 vote May 14
You may also be interested in...
Lurie Joins FDA: Critic Of Agency, Industry Will Help Make Regulatory Policy
One of the most outspoken critics of the device industry and FDA's device center has been named to a top-level position within the agency
Lurie Joins FDA: Critic Of Agency, Industry Will Help Make Regulatory Policy
One of the most outspoken critics of the device industry and FDA's device center has been named to a top-level position within the agency
Covidien's Spine Surgery Sealant To Launch In U.S. Next Month
Covidien plans to begin U.S. shipment of its DuraSeal Xact dural repair sealant for spine surgery at the beginning of October, after receiving FDA approval Sept. 4